The Scientist

» drug development, culture and ecology

Most Recent

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.

0 Comments

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Book Excerpt from <em>Wondrous Truths</em>

Book Excerpt from Wondrous Truths

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Hot Off the Presses

Hot Off the Presses

By | June 1, 2016

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

3 Comments

image: Antibiotic Affects Cow Dung

Antibiotic Affects Cow Dung

By | May 25, 2016

Researchers assess some of the downstream effects of treating livestock with a broad-spectrum antibiotic.

3 Comments

image: Population Ecologist Dies

Population Ecologist Dies

By | May 18, 2016

Ilkka Hanski of the University of Helsinki has passed away at age 63.

0 Comments

image: Pfizer Scoops Anacor for $5.3 Billion

Pfizer Scoops Anacor for $5.3 Billion

By | May 17, 2016

The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham